Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Background Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma. Meth...
Main Authors: | , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
Public Library of Science
2011
|
Online Access: | http://hdl.handle.net/1721.1/66570 |